| Issue Date | Title | Author(s) |
| 6-Oct-2015 | APOBEC3B mediated cytidine deamination is required for estrogen receptor action in breast cancer | Periyasamy, M; Patel, H; Lai, C-F; Nguyen, VTM; Nevedomskaya, E, et al |
| 6-Aug-2019 | Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion | Nguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al |
| 19-Aug-2019 | Author Corrections: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ER alpha breast cancer | Perone, Y; Farrugia, AJ; Rodriguez-Meira, A; Gyorffy, B; Ion, C, et al |
| 14-Jun-2016 | CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancer | Patel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al |
| 27-Nov-2015 | Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion | Nguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al |
| 5-Oct-2022 | Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer | Harrod, A; Lai, C; Goldsbrough, I; Simmons, G; Oppermans, N, et al |
| 21-Sep-2020 | Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments | Palinkas, HL; Bekesi, A; Rona, G; Pongor, L; Papp, G, et al |
| 20-Nov-2020 | Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK directed activation of NF-κB | Periyasamy, M; Singh, A; Gemma, C; Farzan, R; Allsopp, R, et al |
| 15-Jun-2015 | The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer. | Magnani, L; Patten, DK; Nguyen, VTM; Hong, SP; Steel, JH, et al |